GAINESVILLE & BOCA RATON, Fla.--(EON: Enhanced Online News)--The Institute for Commercialization of Public Research (the Institute) announced today that it has finalized a funding agreement with Gainesville-based OBMedical Company. OBMedical has developed the LaborView™ sensor system that measures labor contractions as well as maternal and fetal heart rates.
“OBMedical is addressing a critical need to improve the overall health of women and the safety of babies.”
LaborView™, technology jointly developed by the University of Florida and Convergent Engineering, is a technologically-advanced, wireless electronic maternal-fetal monitor. According to company President Weaver Gaines, “LaborView grows out of over a decade of biomedical research across multiple disciplines, resulting in an innovative solution that is compatible with legacy electronic fetal monitors. Knowledge around the birth process has changed over the last 40 years, but technology has not. We intend for LaborView to take maternal fetal monitoring to the cutting edge, where it should be. The Institute funds will help support the remaining clinical performance trial, industrial design, and design for manufacturing necessary for our filing for 510(k) clearance.”
“OBMedical is addressing a critical need to improve the overall health of women and the safety of babies.” said Jamie Grooms, Institute Chief Executive Officer. “The Institute has enjoyed learning about company progress to date, and looks forward to participating in OBMedical’s future success.”
About the Institute
Formed by the Florida Legislature in 2007, the Institute for Commercialization of Public Research is a non-profit organization that works collaboratively with the technology licensing and commercialization offices of Florida’s state universities and private research institutions to leverage a $2B+ research base and form investable companies that create clean jobs in new industries that are driving the global economy. Over 100 new company projects have been identified across the state, and in the Institute deploys both company building and company funding programs to promising Florida companies. Twenty companies have been funded since the program’s inception. http://www.florida-institute.com.
About OBMedical Company Delivering Success™
OBMedical (obmedco.com) is a medical device company founded in 2012, which has developed LaborView™, a wireless, abdominal electrode-based, electronic maternal-fetal monitor sensor system that will, upon FDA clearance, provide an advanced alternative to the current external sensors with a reliable and comfortable system to enable safer and more cost-effective obstetric monitoring with greater patient satisfaction. The Company’s proprietary technology makes use of neural networks, signal processing, information theory, data fusion, artificial intelligence, and the clinical experience of the OB-GYN Department at the University of Florida’s College of Medicine. LaborView is a Class II, non-significant risk device currently in performance clinical trials expected to lead to a filing for 510(k) clearance in 2014.